Dr Reddys Laboratories Ltd RDY Fundamentals and Key Ratios

Dr. Reddy's Laboratories Ltd (RDY) Fundamentals


Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets.

Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets.

SHARE INFORMATION
Market Cap	$ 9,029,484,923
Shares Outstanding	166,105,315
Float	166,105,315
Percent Float	100.0%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.33
Latest Fiscal Revenue	$ 2,824,387,034
Latest Fiscal EPS	$ 1.87
Latest Fiscal Date	2022-03-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	2022-08-01
Dividend Rate	$ 0.38
Dividend Yield	0.7%
Payment Cash	Cash

HOLDERS
Institutions	371
Institutional Holdings Date	2023-02-28
Institutional Bought Previous 3 Months	1,078,825
Institutional Holdings Percent	14.9%
Institutional Sold Previous 3 Months	2,251,531
Insider Holdings Date	-
Insider Bought Previous 3 Months	-
Insider Holdings Percent	0.0
Insider Sold Previous 3 Months	-
Insider Shares Owned	-

TRADING INFO
52 Week High	$ 58.28
52 Week Low	$ 49.59
52 Week High Change	$ 3.17
21 Day Moving Average	$ 53.98
21 Day Extended Moving Average	$ 54.1119
50 Day Moving Average	$ 53.894
50 Day Extended Moving Average	$ 53.9501
200 Day Moving Average	$ 53.6809
200 Day Extended Moving Average	$ 54.3633
10 Day Average Volume	225,508
20 Day Average Volume	198,891
30 Day Average Volume	186,637
50 Day Average Volume	183,008
Alpha	0.006856
Beta	0.4849
Standard Deviation	0.077299
R2	0.114133
7 Day Price Change	$ 0.98
7 Day Percent Change	1.84%
21 Day Price Change	$ 1.16
21 Day Percent Change	2.18%
30 Day Price Change	$ 0.00
30 Day Percent Change	0.0%
Month to Date Price Change	$ 2.11
Month to Date Percent Change	4.04%
Quarter to Date Price Change	$ 2.61
Quarter to Date Percent Change	5.04%
180 Day Price Change	$ 3.04
180 Day Percent Change	5.92%
200 Day Price Change	$ 2.40
200 Day Percent Change	4.62%
Year to Date Price Change	$ 2.61
Year to Date Percent Change	5.04%

PROFITABILITY
EBIT Margin	21.5%
EBITDA Margin	21.5%
Pre-Tax Profit Margin	10.5%
Profit Margin Count	15.09%
Gross Margin	55.7%
Profit Margin TOT	15.09%

INCOME STATEMENTS
Revenue	$ 2,948,367,377
Revenue Per Share	$ 17.75
Revenue (3 Years)	$ 9.39
Revenue (5 Years)	$ 9.46

FINANCIAL STRENGTH
Price to Tangible Book	3.40
Total Debt To Equity	0.10
Int Coverage	36.70
Current Ratio	2.20
Leverage Ratio	1.10
Quick Ratio	1.30
Long Term Debt To Capital	0.01

VALUATION MEASURES
PE Ratio	20.60
Enterprise Value	$ 8,768,028,524
Price to Sales	3.0625
Price to Free Cash	31.00
PE High Last 5 Years	53.30
Price To Book	3.40
Price To Cash Flow	17.70
PE Low Last 5 Years	20.60
Price to Tangible Book	3.40

MANAGEMENT EFFECTIVENESS
Receivables Turnover	7.50
Invoice Turnover	2.10
Assets Turnover	1.70
Return Assets	12.31
Return on Equity	17.35
Return on Capital	17.01

PROFILE INFO
Issue Type	AD
SEC Type	DR
Auditor	Ernst & Young Associates LLP
CEO	Erez Israeli
Emplyoees	24795
Last Audit	UQ
CIK	0001135951
Industry	Drug Manufacturers
Sector	Healthcare
NAICS	-

CONTACT INFO
Address	8-2-337, Road No. 3 Banjara Hills Hyderabad, TG 500 034
Website	https://www.drreddys.com
Facsimile	+91 4049002999
Telephone	+91 4049002900
Email	shares@drreddys.com

Boards:

Quotes:

RDY